Hans Duyvejonck
Overview
Explore the profile of Hans Duyvejonck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Overfelt S, Duyvejonck H, Baeke F, De Rycke R, Merabishvili M, Vermeulen S, et al.
PLoS One
. 2024 Dec;
19(12):e0313774.
PMID: 39625917
To use phages in a personalized therapy and industrial applications, an accurate quantification is needed. The gold standard method, namely the culture-based double agar overlay (DAO) method, provides an accurate...
2.
Mulinganya M, De Keyser K, Mongane I, Kampara M, De Vulder A, Boelens J, et al.
Front Glob Womens Health
. 2024 Jun;
5:1339821.
PMID: 38847001
Introduction: Vaginal colonization (CC) can lead to vulvovaginal candidiasis, the second most prevalent vaginal condition worldwide, and has been associated with adverse birth outcomes. However, no data on CC in...
3.
McCoubrey L, Seegobin N, Sangfuang N, Moens F, Duyvejonck H, Declerck E, et al.
J Control Release
. 2024 Apr;
369:630-641.
PMID: 38599548
Successful treatment of ulcerative colitis (UC) is highly dependent on several parameters, including dosing regimen and the ability to deliver drugs to the disease site. In this study two strategies...
4.
Duyvejonck H, Merabishvili M, Vaneechoutte M, De Soir S, Wright R, Friman V, et al.
Viruses
. 2021 Jun;
13(5).
PMID: 34066841
In Belgium, the incorporation of phages into magistral preparations for human application has been permitted since 2018. The stability of such preparations is of high importance to guarantee quality and...
5.
Lebeaux D, Merabishvili M, Caudron E, Lannoy D, Van Simaey L, Duyvejonck H, et al.
Viruses
. 2021 Jan;
13(1).
PMID: 33466377
Bacteriophages are a promising therapeutic strategy among cystic fibrosis and lung-transplanted patients, considering the high frequency of colonization/infection caused by pandrug-resistant bacteria. However, little clinical data are available regarding the...
6.
Rodriguez A, Duyvejonck H, van Belleghem J, Gryp T, Van Simaey L, Vermeulen S, et al.
PLoS One
. 2020 Feb;
15(2):e0229423.
PMID: 32084228
RNA quality and quantity are important factors for ensuring the accuracy of gene expression analysis and other RNA-based downstream applications. Thus far, only a limited number of methodological studies have...
7.
Duyvejonck H, Merabishvili M, Pirnay J, De Vos D, Verbeken G, Van Belleghem J, et al.
Sci Rep
. 2019 Sep;
9(1):13893.
PMID: 31554892
To determine phage titers accurately, reproducibly and in a non-laborious and cost-effective manner, we describe the development of a qPCR platform for molecular quantification of five phages present in bacteriophage...
8.
Duyvejonck H, Cools P, Decruyenaere J, Roelens K, Noens L, Vermeulen S, et al.
PLoS One
. 2015 Sep;
10(9):e0139501.
PMID: 26406230
No abstract available.
9.
Duyvejonck H, Cools P, Decruyenaere J, Roelens K, Noens L, Vermeulen S, et al.
PLoS One
. 2015 Aug;
10(8):e0132149.
PMID: 26295947
Aim: Candida species are known as opportunistic pathogens, and a possible cause of invasive infections. Because of their species-specific antimycotic resistance patterns, reliable techniques for their detection, quantification and identification...